Target intelligence / Profile preview

Copper ion (Cu) (Cu)

Target
Cu
Molecular classification
Metal ion, Enzyme cofactor, Other
01

Overview

Copper is an essential trace element that serves as a vital cofactor for numerous enzymes involved in energy production, iron metabolism, and antioxidant defense (PubChem). In the context of the ES-Cu complex, copper is utilized as a cytotoxic agent through the action of elesclomol, a small-molecule copper ionophore. Elesclomol binds extracellular Cu2+ with high affinity, forming a stable 1:2 metal-ligand complex that facilitates the transport of copper across cellular and mitochondrial membranes (Kirshner et al., Mol Cancer Ther, 2008). Once inside the mitochondria, the copper ion is reduced from Cu2+ to Cu+, a process that generates high levels of reactive oxygen species (ROS) and disrupts the electron transport chain. This influx of copper triggers a specific form of regulated cell death known as cuproptosis, which is distinct from apoptosis and ferroptosis (Tsvetkov et al., Science, 2022). Cuproptosis is characterized by the direct binding of copper to lipoylated components of the tricarboxylic acid (TCA) cycle, leading to protein aggregation and subsequent cellular metabolic collapse. This mechanism is particularly effective against cancer cells that exhibit high mitochondrial activity and a reliance on oxidative phosphorylation.

Other names
Cupric ionCuprous ionCopper(II)Copper(I)ES-Cu complexElesclomol-copper complex
02

Mechanism of action

Copper ionophores like elesclomol bind extracellular Cu2+ to form a lipophilic complex that enters the mitochondria, where copper is reduced to Cu+, leading to the generation of reactive oxygen species (ROS) and the induction of cuproptosis via the aggregation of lipoylated TCA cycle enzymes (Tsvetkov et al., Science, 2022; Kirshner et al., Mol Cancer Ther, 2008).

03

Biological functions

Redox signalingMitochondrial metabolismOxidative stress inductionEnzyme catalysisOther
04

Disease associations

CancerWilson diseaseMenkes diseaseNeurodegenerative diseaseOther
05

Safety considerations

Systemic copper toxicityHepatotoxicityOxidative damage to healthy tissuesPotential for severe gastrointestinal distressNeurological impairment in cases of chronic overexposure
06

Interacting drugs

Elesclomol (STA-4783)

4 more in the full profile.

07

Biomarkers

FDX1 expressionLipoic acid pathway protein levels (e.g., DLAT)Serum ceruloplasminIntracellular copper concentrationMitochondrial metabolic activity

Beyond the preview

Go deeper on Copper ion (Cu) (Cu).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper ion (Cu) (Cu).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call